Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A global research team, led by Wake Forest University’s Dr. Quentin Perrier, has successfully 3D-printed functioning human ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a ...

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market are the rising prevalence of diabetes, the growing preference for pens over ...

The document also addresses non-insulin injectables including glucagon-like peptide 1 receptor agonists and glucagon. Some patients will have initially learned injection techniques with these ...

Other side effects include injection site reactions, itching, rash, lipodystrophy, weight gain, and swollen hands and feet. The rapid-acting insulin aspart biosimilar joins two prior long-acting ...

The global market for Diabetes Injection Pens was estimated at US$8.5 Billion in 2023 and is projected to reach US$12.5 Billion by 2030, growing at a CAGR of 5.7% from 2023 to 2030.

The global market for Diabetes Injection Pens was estimated at US$8.5 Billion in 2023 and is projected to reach US$12.5 Billion by 2030, growing at a CAGR of 5.7% from 2023 to 2030. This comprehensive ...